Document Detail


Controlling lipids in a high-risk population with documented coronary artery disease for secondary prevention: are we doing enough?
MedLine Citation:
PMID:  20305563     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The prevalence of high-density lipoprotein cholesterol (HDL-C) in patients who have achieved low-density lipoprotein cholesterol (LDL-C) targets in the current era of universal statin therapy remains unknown. We conducted a study to determine the prevalence of low HDL-C in patients with documented coronary artery disease, and to determine the lipid-lowering treatment patterns in secondary prevention of coronary artery disease.
METHODS: In this retrospective cohort analysis, data were obtained from the electronic database of a cardiology clinic. The Joint British Society 2 criteria were used defining low HDL-C as less than 1 mmol/l in males and less than 1.2 mmol/l in females. We compared the prevalence of low HDL-C across the following categories of LDL-C: less than 2, 2-2.5, and greater than 2.5 mmol/l.
RESULTS: Two thousand and eighty-seven patients with a mean age of 64.34±11.94 years constituted the study sample. About 36.6% of patients in this study were found to have low HDL-C. Irrespective of sex, low HDL-C was prevalent across all levels of LDL-C, but interestingly this was most prevalent in patients with a LDL-C less than 2 mmol/l (43.06%). HDL-C level of 1.16±0.97 mmol/l in patients with LDL-C less than 2 mmol/l was significantly lower than 1.22±0.33 mmol/l in patients with LDL-C greater than 2 mmol/l, P value less than 0.01. There was a poor correlation between levels of HDL-C and LDL-C in the study population irrespective of sex or statin therapy.
CONCLUSION: This study shows widely prevalent low HDL-C levels in high-risk patients across the spectrum of LDL-C levels despite statin therapy. There was no correlation between the LDL-C and HDL-C levels implying their independent relationship and, thus, the need to treat them independently.
Authors:
Mukesh Singh; Shui Hao Chin; Paul D Giles; David Crothers; Karim Al-Allaf; Jawad M Khan
Related Documents :
12438663 - The association between low birth weight and high levels of cholesterol is not due to a...
12548313 - Plant sterol-enriched spread enhances the cholesterol-lowering potential of a fat-reduc...
18425433 - The effect of peripheral administration of zinc on food intake in rats fed zn-adequate ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology     Volume:  17     ISSN:  1741-8275     ISO Abbreviation:  Eur J Cardiovasc Prev Rehabil     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-05     Completed Date:  2011-02-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101192000     Medline TA:  Eur J Cardiovasc Prev Rehabil     Country:  England    
Other Details:
Languages:  eng     Pagination:  556-61     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Chicago Medical School, North Chicago, Ilinois 60064, USA. drmukeshsingh@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Biological Markers / blood
Chi-Square Distribution
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Coronary Artery Disease / etiology,  prevention & control,  therapy*
Drug Utilization
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hypercholesterolemia / blood,  complications,  drug therapy*
Linear Models
Male
Middle Aged
Physician's Practice Patterns*
Practice Guidelines as Topic
Recurrence / prevention & control
Retrospective Studies
Risk Assessment
Risk Factors
Secondary Prevention / methods*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Angiogenesis and vasculogenesis in rheumatoid arthritis.
Next Document:  Depressive symptoms and heart rate variability in younger women after an acute coronary event.